Recent Finacing
Recent Raise
Alphamab Oncology is a clinical-stage biopharmaceutical company that discovers, develops and manufactures oncology biologics using protein engineering, bispecific and single-domain antibody platforms, advancing PD-L1, PD-L1/CTLA-4 and anti-HER2 clinical programs.
